Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Clinical trial NCT04335682 · COMPLETED

Trial details

NCT number: NCT04335682
Sponsor: Alliance Foundation Trials, LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Prostate Cancer Metastatic Prostate Cancer Castrate Resistant Prostate Cancer Hormone Sensitive Prostate Cancer Non-metastatic Prostate Cancer

Start date: 2021-08-17
Primary completion: 2025-09-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.